Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 135

1.

Characterization and Functions of Protease-Activated Receptor 2 in Obesity, Diabetes, and Metabolic Syndrome: A Systematic Review.

Kagota S, Maruyama K, McGuire JJ.

Biomed Res Int. 2016;2016:3130496. doi: 10.1155/2016/3130496. Epub 2016 Feb 23. Review.

2.

[Role/function of protease-activated receptor 2 on vascular endothelium in metabolic syndrome].

Maruyama K, McGuire JJ, Shinozuka K, Kagota S.

Nihon Yakurigaku Zasshi. 2016 Mar;147(3):135-8. doi: 10.1254/fpj.147.135. Japanese. No abstract available.

PMID:
26960771
3.

Enhanced Nitric Oxide Synthase Activation via Protease-Activated Receptor 2 Is Involved in the Preserved Vasodilation in Aortas from Metabolic Syndrome Rats.

Maruyama K, Kagota S, McGuire JJ, Wakuda H, Yoshikawa N, Nakamura K, Shinozuka K.

J Vasc Res. 2015;52(4):232-43. doi: 10.1159/000442415. Epub 2016 Jan 14.

PMID:
26760532
4.

Corrigendum: Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Sep 3;525(7567):144. doi: 10.1038/nature14608. Epub 2015 Jul 1. No abstract available.

PMID:
26131938
5.

Greenland supraglacial lake drainages triggered by hydrologically induced basal slip.

Stevens LA, Behn MD, McGuire JJ, Das SB, Joughin I, Herring T, Shean DE, King MA.

Nature. 2015 Jun 4;522(7554):73-6. doi: 10.1038/nature14480. Erratum in: Nature. 2015 Sep 3;525(7567):144.

PMID:
26040890
6.

Small caliber arterial endothelial cells calcium signals elicited by PAR2 are preserved from endothelial dysfunction.

Hennessey JC, Stuyvers BD, McGuire JJ.

Pharmacol Res Perspect. 2015 Mar;3(2):e00112. doi: 10.1002/prp2.112.

7.

Disturbance of vasodilation via protease-activated receptor 2 in SHRSP.Z-Lepr fa/IzmDmcr rats with metabolic syndrome.

Kagota S, Maruyama K, Wakuda H, McGuire JJ, Yoshikawa N, Nakamura K, Shinozuka K.

Vascul Pharmacol. 2014 Oct;63(1):46-54. doi: 10.1016/j.vph.2014.06.005. Epub 2014 Aug 7.

PMID:
25109437
8.

Effects of chronic in-vivo treatments with protease-activated receptor 2 agonist on endothelium function and blood pressures in mice.

Hughes KH, Wijekoon EP, Valcour JE, Chia EW, McGuire JJ.

Can J Physiol Pharmacol. 2013 Apr;91(4):295-305. doi: 10.1139/cjpp-2012-0266. Epub 2012 Dec 19.

9.

Attenuated vasodilator effectiveness of protease-activated receptor 2 agonist in heterozygous par2 knockout mice.

Hennessey JC, McGuire JJ.

PLoS One. 2013;8(2):e55965. doi: 10.1371/journal.pone.0055965. Epub 2013 Feb 7.

10.
11.

Geophysics. A rogue earthquake off Sumatra.

McGuire JJ, Beroza GC.

Science. 2012 Jun 1;336(6085):1118-9. doi: 10.1126/science.1223983. Epub 2012 May 10. No abstract available.

PMID:
22582017
12.

Protection of protease-activated receptor 2 mediated vasodilatation against angiotensin II-induced vascular dysfunction in mice.

Chia E, Kagota S, Wijekoon EP, McGuire JJ.

BMC Pharmacol. 2011 Sep 28;11:10. doi: 10.1186/1471-2210-11-10.

13.

Preserved arterial vasodilatation via endothelial protease-activated receptor-2 in obese type 2 diabetic mice.

Kagota S, Chia E, McGuire JJ.

Br J Pharmacol. 2011 Sep;164(2):358-71. doi: 10.1111/j.1476-5381.2011.01356.x.

14.
15.

Protease-activated receptor 2 and bradykinin-mediated vasodilation in the cerebral arteries of stroke-prone rats.

Smeda JS, McGuire JJ, Daneshtalab N.

Peptides. 2010 Feb;31(2):227-37. doi: 10.1016/j.peptides.2009.11.026. Epub 2009 Nov 30.

PMID:
19954757
16.

Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate.

McGuire JJ, Bartley DM, Tomsho JW, Haile WH, Coward JK.

Arch Biochem Biophys. 2009 Aug 15;488(2):140-5. doi: 10.1016/j.abb.2009.06.017. Epub 2009 Jun 27. Erratum in: Arch Biochem Biophys. 2010 Jan 15;493(2):250.

17.

Developmental programming of lipid metabolism and aortic vascular function in C57BL/6 mice: a novel study suggesting an involvement of LDL-receptor.

Chechi K, McGuire JJ, Cheema SK.

Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1029-40. doi: 10.1152/ajpregu.90932.2008. Epub 2009 Feb 4. Erratum in: Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R911.

18.

Metabolism-blocked antifolates as potential anti-rheumatoid arthritis agents: 4-amino-4-deoxy-5,8,10-trideazapteroyl-d,l-4'-methyleneglutamic acid (CH-1504) and its analogs.

McGuire JJ, Haile WH.

Biochem Pharmacol. 2009 Apr 1;77(7):1161-72. doi: 10.1016/j.bcp.2008.12.020. Epub 2009 Jan 6.

PMID:
19174154
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk